Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999

被引:111
作者
Valdez, H
Chowdhry, TK
Asaad, R
Woolley, IJ
Davis, T
Davidson, R
Beinker, N
Gripshover, BM
Salata, RA
McComsey, G
Weissman, SB
Lederman, MM
机构
[1] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
D O I
10.1086/320164
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed the deaths in an outpatient human immunodeficiency virus (HIV) care clinic at University Hospitals in Cleveland from January 1995 through December 1999. The number of annual deaths decreased progressively, from 112 in 1995 to 32 in 1999. The median final CD4(+) cell count before death increased progressively from 10 cells/muL in 1995 to 90 cells/muL in 1999 (P < .01); 20%-25% of patients who died from 1997 through 1999 had plasma HIV RNA levels below detection limits. From 1995 through 1998, deaths due to infection, to end- stage acquired immune deficiency syndrome, and to malignancies decreased, whereas the proportion of deaths due to end-organ failures and of uncertain relationship to HIV infection increased. The spectrum of mortality in HIV disease has changed recently; although opportunistic infections cause death less frequently, deaths are occurring in people who have control of HIV replication and with some preservation of immune function. These observations underscore the need to monitor the etiologies of HIV-associated mortality and to better our understanding of the relationships among immune defenses, treatment-related toxicities, and end-organ failure in patients with HIV disease.
引用
收藏
页码:1487 / 1493
页数:7
相关论文
共 26 条
[1]  
Arribas JR, 1998, AIDS, V12, P1722
[2]   RETRACTED: Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients (Retracted Article. See vol 347, pg 140, 2002) [J].
Barbaro, G ;
Di Lorenzo, G ;
Grisorio, B ;
Barbarini, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (16) :1093-1099
[3]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[4]   Severe hepatitis in three AIDS patients treated with indinavir [J].
Brau, N ;
Leaf, HL ;
Wieczorek, RL ;
Margolis, DM .
LANCET, 1997, 349 (9056) :924-925
[5]  
Buchbinder SP, 1999, J ACQ IMMUN DEF SYND, V21, pS23
[6]  
CDC (Cent. Dis. Control Prev.), 1992, MMWR RECOMM REP, V41, P1
[7]   Declining HIV/AIDS mortality in New York City [J].
Chiasson, MA ;
Berenson, L ;
Li, WH ;
Schwartz, S ;
Singh, T ;
Forlenza, S ;
Mojica, BA ;
Hamburg, MA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (01) :59-64
[8]   CONGESTIVE CARDIOMYOPATHY IN ASSOCIATION WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
COHEN, IS ;
ANDERSON, DW ;
VIRMANI, R ;
REEN, BM ;
MACHER, AM ;
SENNESH, J ;
DILORENZO, P ;
REDFIELD, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (10) :628-630
[9]   Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C [J].
Darby, SC ;
Ewart, DW ;
Giangrande, PLF ;
Spooner, RJD ;
Rizza, CR ;
Dusheiko, GM ;
Lee, CA ;
Ludlam, CA ;
Preston, FE .
LANCET, 1997, 350 (9089) :1425-1431
[10]   HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy [J].
Deeks, SG ;
Hecht, FM ;
Swanson, M ;
Elbeik, T ;
Loftus, R ;
Cohen, PT ;
Grant, RM .
AIDS, 1999, 13 (06) :F35-F43